3C-BOH
3C-BOH, also known as β-methoxy-3,4-methylenedioxyamphetamine or as BOMDA, is a psychoactive drug of the phenethylamine, amphetamine, MDxx, and BOx families related to 3,4-methylenedioxyamphetamine. It is the β-methoxy derivative of MDA and the amphetamine analogue of BOH. The drug is active at a dose of 40 to 70mg orally with a duration of 3 to 6hours. It is said to produce "amphetamine-like effects", as well as physical side effects and temporary body stiffness. 3C-BOH acts as a monoamine releasing agent and reuptake inhibitor, including of serotonin and norepinephrine, and additionally acts as an agonist of the serotonin 5-HT2 receptors, among other actions. The compound can exist as four stereoisomers, with individual assessment of each individual isomer still needed. 3C-BOH was first described in the scientific literature by Daniel Trachsel and colleagues in 2013 via personal communication with another person.